Final phase of human clinical trial “covishield” starts from tuesday. Serum institute of india begins this covid19 vaccine human trial on healthy indians at Bharati Vidyapeeth Medical college, pune. Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford. Around 1,600 people aged above 18 years are likely to participate in the trials.
